Shorter radiation schedule for resistant brain metastases
Part of Brain & nervous system, Cancer clinical trials.
This trial tests a shorter course of high-precision radiation for brain tumors that have spread from certain cancers like melanoma, kidney, digestive, sarcoma, or prostate. The goal is to see if giving the radiation over 3 days instead of 5 is just as effective and easier for patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have 1 to 5 brain tumors that have not been removed surgically, and your cancer type is one of these: melanoma, kidney, digestive, sarcoma, or prostate.
- You are able to care for yourself (score above 50% on the Karnofsky scale).
- You have not had radiation to the brain before.
- You are not allergic to gadolinium (the MRI contrast dye) and can have an MRI.
- You are not pregnant or breastfeeding, and you are not under legal guardianship.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests giving targeted radiation while surgeons are operating to treat brain metastases. It may help control the cancer locally at the time of surgery, especially for certain single lesions.
This trial is for people with cancer that has spread to the brain (brain metastases). It tests a new approach where you start a systemic therapy (drugs that travel through your body) and later add focused radiation to the brain tumors, instead of treating them right away. The goal is to see if this sequence works well and avoids unnecessary side effects.
This Phase 2 study tests a precise, no-head-frame radiation technique to treat brain metastases. It may help by aiming radiation tightly at the tumors while limiting exposure to nearby healthy brain.
This trial tests a new approach for people with a single large brain tumor that has spread from another cancer. You would receive a short, focused dose of radiation (stereotactic radiosurgery) in small, separate treatments, followed by surgery to remove the tumor. The goal is to see if this combination works better than the usual treatment.
This study tests a type of radiation treatment for people with one or more brain tumors that are larger than usual (2 to 5 centimeters). It aims to see if this approach is safe and effective, and may be an option if you are not having immediate surgery.
This trial tests two different radiation margins (how much healthy tissue is included around a brain tumor) during a single treatment session. It aims to see which margin is better at controlling brain metastases while reducing side effects.
Hear when a new Brain Metastases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.